Anethole (Phenylpropene)

Anethole is a phenolic compound found in fennel and star anise that demonstrates anticancer properties through apoptosis induction and cell cycle arrest. Clinical research shows anethole derivatives can reduce lung cancer progression by 46% in high-risk smokers.

Origin & History

Anethole is a bioactive phenylpropene compound found in the essential oils of anise and fennel plants, commonly used as a food preservative and flavoring agent. The compound exists primarily in the trans-anethole form (4-methoxypropenylbenzene) and is extracted from plant essential oils through standard distillation or solvent extraction methods.

Historical & Cultural Context

While the research dossier does not provide detailed traditional use information, anethole is derived from anise and fennel plants with long histories in culinary and traditional medicine applications across Mediterranean and Asian cultures. The compound is recognized as GRAS (Generally Recognized as Safe) by FEMA for flavoring use.

Health Benefits

• Lung cancer chemoprevention: One human RCT showed ADT (anethole derivative) reduced disease progression by 46% in smokers with bronchial dysplasia (moderate evidence)
• Anti-cancer effects: Preclinical studies demonstrate apoptosis induction and cell cycle arrest in various cancer cells, including enhanced efficacy with chemotherapy (preliminary evidence)
• Neuroprotective effects: Animal studies show improved memory and reduced brain inflammation through cholinesterase inhibition and antioxidant activity (preliminary evidence)
• Anti-inflammatory action: Laboratory research indicates reduction of pro-inflammatory cytokines TNF-α, IL-1β, and IL-6 (preliminary evidence)
• Antioxidant properties: Animal models demonstrate reduced oxidative stress markers and increased total antioxidant capacity (preliminary evidence)

How It Works

Anethole induces cancer cell apoptosis through mitochondrial membrane depolarization and activation of caspase-3 and caspase-9 pathways. It arrests cell cycle progression at G0/G1 phase by downregulating cyclin D1 and CDK4 expression. The compound also modulates NF-κB and p53 signaling cascades to promote tumor suppressor activity.

Scientific Research

Human clinical evidence remains limited to one randomized controlled trial of anethole dithiolethione (ADT) in 112 smokers, which demonstrated significant reduction in bronchial dysplasia progression over 6 months. The majority of research consists of preclinical in vitro and animal studies investigating anti-cancer, neuroprotective, and anti-inflammatory mechanisms. Comprehensive human clinical trials are lacking for most proposed therapeutic applications.

Clinical Summary

One randomized controlled trial evaluated ADT (anethole dithiolethione) in 60 smokers with bronchial dysplasia, showing 46% reduction in disease progression compared to placebo over 6 months. The study represents moderate-quality evidence for lung cancer chemoprevention in high-risk populations. Most other evidence comes from preclinical studies demonstrating anticancer effects across multiple cell lines including breast, colon, and prostate cancer models. Human clinical data remains limited to this single lung cancer prevention trial.

Nutritional Profile

Anethole is a pure phenylpropanoid aromatic compound (trans-anethole being the predominant naturally occurring isomer, >95% in most extracts), not a whole food and therefore contains no macronutrients, fiber, vitamins, or minerals in its isolated form. Molecular formula: C10H12O; molecular weight: 148.20 g/mol. It is the primary bioactive constituent of anise (Pimpinella anisum, ~1.5–3% essential oil content, of which anethole comprises 80–95%), star anise (Illicium verum, ~5–8% essential oil, 80–90% anethole), and fennel (Foeniculum vulgare, ~2–6% essential oil, 50–80% anethole). As a phenylpropene, it is structurally related to estragole and eugenol. Bioactive concentration in commercial star anise essential oil: approximately 800–900 mg/g of oil. trans-Anethole has an estimated oral bioavailability that is moderate; it undergoes hepatic oxidative metabolism via CYP450 enzymes (primarily CYP1A2 and CYP2A6) to form para-anisaldehyde, anise ketone (1-phenyl-2-propanone derivative), and epoxide intermediates. The cis-isomer is considered more toxic and is present only in trace amounts (<0.1%) in food-grade sources. Log P (octanol-water partition coefficient): ~3.0, indicating moderate lipophilicity, which facilitates membrane permeability and oral absorption. No caloric or micronutrient value is assigned as it functions strictly as a bioactive phytochemical. ADI (acceptable daily intake) has not been formally established by EFSA or FDA for isolated anethole, though it is classified as GRAS (Generally Recognized As Safe) at food-use levels.

Preparation & Dosage

Human clinical trial: Anethole dithiolethione (ADT) 25 mg orally three times daily (75 mg total) for 6 months. Animal studies used: 10-100 mg/kg for antidepressant effects in mice; 125-500 mg/kg for cognitive enhancement in rats. No standardized dosing established for pure anethole in humans. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Fennel extract, Star anise, Licorice root, Curcumin, Green tea extract

Safety & Interactions

Anethole is generally recognized as safe when consumed in typical food amounts found in fennel and anise. High doses may cause allergic reactions in sensitive individuals, particularly those with existing plant allergies. The compound may interact with estrogen-sensitive medications due to mild estrogenic activity. Pregnant women should avoid therapeutic doses as anethole can stimulate uterine contractions, though culinary amounts appear safe.